Jacob Chacko, PRESIDENT AND CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 175,078 shares at $12.05 ($2.1M) on 2025-10-01, disclosed to the SEC on 2025-10-02.
Scheduled sale ($2.1M) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.01 | 34,538 | $415K | 19.7% |
| 2 | $12.01 | 34,538 | $415K | 19.7% |
| 3 | $12.05 | 53,001 | $639K | 30.3% |
| 4 | $12.05 | 53,001 | $639K | 30.3% |
| Total | $12.03 avg | 175,078 | $2.1M | 100% |
| Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |
| ORIC | SELL | 2024-03-08 | $648K | — | Filing → |